Good Clinical Practices on Argon Plasma Coagulation Treatment for Weight Regain Associated with Dilated Gastrojejunostomy Following Roux-en-Y Gastric Bypass: a Brazilian-Modified Delphi Consensus.

INTRODUCTION: Argon plasma coagulation (APC) alone is effective and safe at treating weight regain following Roux-en-Y gastric bypass (RYGB). However, technical details of the treatment vary widely among studies. Therefore, we aimed to create good clinical practice guidelines through a modified Delphi consensus, including experts from the collaborative Bariatric Endoscopy Brazilian group. METHODS: Forty-one locally renowned experts were invited to the consensus by email. Experiences of > 150 APC-treated cases or authorship of relevant articles were the eligibility criteria. An initial questionnaire with short-answer questions was distributed to the experts. The organizing committee converted the responses into statements for an online 2-day voting webinar. Consensus was defined as more than 67% of positive answers. Three consecutive voting rounds were planned with discussion and statement refinements between rounds. RESULTS: Thirty-seven experts fulfilled eligibility criteria and attended the live webinar voting. The total number of patients treated by the panel was 12,349. By the third round, all 79 statements reached consensus. The recommendations include the definition of dilated gastrojejunal anastomosis as ≥ 15 mm, minimum regain of 20% of the lost weight to indicate the APC therapy, 6 to 8 weeks as the ideal interval between ablation sessions, and stopping treatment when the stoma reaches < 12 mm of breadth. CONCLUSIONS: This consensus provides several recommendations based on a highly experienced panel of endoscopists. Although it covers most aspects of the treatment, the level of evidence is low for the majority of the statements. Therefore, bariatric endoscopists should be constantly attentive to new evidence on APC treatment.

Outcomes of a novel bariatric stent in the management of sleeve gastrectomy leaks: a multicenter study.

BACKGROUND: The management of laparoscopic sleeve gastrectomy leaks remains a challenge. This can be treated with placement of self-expandable metal stents, which are most effective in the acute and early settings. However, migration is a frequent adverse event (AE). Novel, fully covered stents with a larger proximal flare to limit migration designed specifically to treat postsleeve leaks were recently introduced. OBJECTIVES: The aim of this study was to evaluate the safety and efficacy of a novel stent specifically designed for postsleeve leaks treatment. SETTING: Multicenter retrospective study. METHODS: This is a multicenter study, including patients with acute and early post laparoscopic sleeve gastrectomy leaks, treated with a large bariatric stent. The outcomes include technical success, clinical success, and safety profile. A multivariable regression was performed to assess predictors of success. RESULTS: Thirty-seven patients were included (10 acute and 27 early leaks), with 30 stents in the postpyloric (POST) and 7 in the prepyloric position. Technical success was 100%. Mean stent dwell time was 29.08 days. Clinical success was achieved in 78.37%. Leak duration, leak size, and stent dwell time did not correlate with clinical success. During follow-up, 8 patients had stent migration (21.62%) and all were in a POST position. AE poststent removal were also evaluated (prepyloric: 57.14% vs POST: 33.3%, P = .45). There was no difference between prepyloric and POST position in the severe AE analysis. CONCLUSIONS: This novel, large-caliber, fully covered stent specifically designed for sleeve leaks appears to be effective at treating acute and early leaks. However, the large flanges and long stent length do not appear to reduce migration rate and may be associated with higher overall severe AE rates. Avoiding placement in the POST position may help mitigate migration risk; however, owing to the risk profile this stent should be used with caution.

Capsule endoscopy in clinical practice: four years of experience from a single center.

Capsule endoscopy is a diagnostic method of increasing use nowadays, with various applications such as, evaluation of obscure gastrointestinal bleeding, chronic diarrhea and anemia. The experience of 4 years is reported in a retrospective review of 109 medical records to determine the main indications and the most common diagnostic findings and the percentage of positive studies. The main indications were obscure bleeding in 65%, chronic anemia in 8%. Vascular lesions in 33%, being that, hematocistic spot was found in 53% of studies. The location of active bleeding was possible in five patients (4.5%). Capsule endoscopy shows a high diagnostic yield in obscure bleeding.

Capsule endoscopy in clinical practice: four years of experience from a single center / Cápsula endoscópica na prática clínica: quatro anos de experiência de um centro

Capsule endoscopy is a diagnostic method of increasing use nowadays, with various applications such as, evaluation of obscure gastrointestinal bleeding, chronic diarrhea and anemia. The experience of 4 years is reported in a retrospective review of 109 medical records to determine the main indications and the most common diagnostic findings and the percentage of positive studies. The main indications were obscure bleeding in 65 percent, chronic anemia in 8 percent. Vascular lesions in 33 percent, being that, hematocistic spot was found in 53 percent of studies. The location of active bleeding was possible in five patients (4.5 percent). Capsule endoscopy shows a high diagnostic yield in obscure bleeding.

A endoscopia por cápsula é um método cada vez mais empregado na prática clínica, com diversas aplicações tais como: investigação de sangramento gastrointestinal obscuro, diarreia e anemia. A experiência de 4 anos é relatada em revisão retrospectiva de 109 registros médicos objetivando determinar as indicações e achados mais comuns e o percentual de exames positivos. As principais indicações foram: sangramento gastrointestinal obscuro em 65 por cento, anemia crônica em 8 por cento, lesões vasculares em 33 por cento e a mancha hematocística foi observada em 53 por cento dos estudos. A localização do sangramento ativo foi possível em 4,5 por cento dos casos. A endoscopia da cápsula demonstrou bom rendimento diagnóstico no sangramento obscuro.